JP2008507538A5 - - Google Patents

Download PDF

Info

Publication number
JP2008507538A5
JP2008507538A5 JP2007522711A JP2007522711A JP2008507538A5 JP 2008507538 A5 JP2008507538 A5 JP 2008507538A5 JP 2007522711 A JP2007522711 A JP 2007522711A JP 2007522711 A JP2007522711 A JP 2007522711A JP 2008507538 A5 JP2008507538 A5 JP 2008507538A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
composition
substituted
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007522711A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507538A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/025780 external-priority patent/WO2006014762A1/en
Publication of JP2008507538A publication Critical patent/JP2008507538A/ja
Publication of JP2008507538A5 publication Critical patent/JP2008507538A5/ja
Pending legal-status Critical Current

Links

JP2007522711A 2004-07-22 2005-07-20 置換アミドβセクレターゼインヒビター Pending JP2008507538A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59010204P 2004-07-22 2004-07-22
PCT/US2005/025780 WO2006014762A1 (en) 2004-07-22 2005-07-20 Substituted amide beta secretase inhibitors

Publications (2)

Publication Number Publication Date
JP2008507538A JP2008507538A (ja) 2008-03-13
JP2008507538A5 true JP2008507538A5 (cg-RX-API-DMAC7.html) 2008-08-14

Family

ID=35431616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007522711A Pending JP2008507538A (ja) 2004-07-22 2005-07-20 置換アミドβセクレターゼインヒビター

Country Status (12)

Country Link
US (2) US7803802B2 (cg-RX-API-DMAC7.html)
EP (1) EP1781625B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008507538A (cg-RX-API-DMAC7.html)
CN (1) CN101014577A (cg-RX-API-DMAC7.html)
AR (1) AR049726A1 (cg-RX-API-DMAC7.html)
AT (1) ATE491693T1 (cg-RX-API-DMAC7.html)
CA (1) CA2574218A1 (cg-RX-API-DMAC7.html)
DE (1) DE602005025363D1 (cg-RX-API-DMAC7.html)
ES (1) ES2355733T3 (cg-RX-API-DMAC7.html)
MX (1) MX2007000760A (cg-RX-API-DMAC7.html)
TW (1) TW200621249A (cg-RX-API-DMAC7.html)
WO (1) WO2006014762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
ATE482214T1 (de) 2005-06-14 2010-10-15 Schering Corp Aspartylproteasehemmer
WO2006138264A2 (en) 2005-06-14 2006-12-28 Schering Corporation Aspartyl protease inhibitors
CA2653650A1 (en) 2006-06-12 2007-12-21 Schering Corporation Heterocyclic aspartyl protease inhibitors
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
MX2009006228A (es) 2006-12-12 2009-06-22 Schering Corp Inhibidores de aspartil proteasa.
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
CN101848897A (zh) 2007-09-06 2010-09-29 先灵公司 γ分泌酶调节剂
US8487099B2 (en) 2007-11-05 2013-07-16 Merck Sharp & Dohme Corp. Gamma secretase modulators
WO2009076352A1 (en) 2007-12-11 2009-06-18 Schering Corporation Gamma secretase modulators
AU2009239536C1 (en) 2008-04-22 2012-12-13 Merck Sharp & Dohme Corp. Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
JP5503663B2 (ja) 2008-11-13 2014-05-28 メルク・シャープ・アンド・ドーム・コーポレーション ガンマセクレターゼモジュレータ
AU2009330233A1 (en) 2008-12-22 2011-07-07 Merck Sharp & Dohme Corp. Gamma secretase modulators
EP2379566A2 (en) 2008-12-22 2011-10-26 Schering Corporation Gamma secretase modulators
WO2010147969A2 (en) 2009-06-16 2010-12-23 Schering Corporation Gamma secretase modulators
US20120245158A1 (en) 2009-06-16 2012-09-27 Xianhai Huang Gamma secretase modulators
EP2443118A1 (en) 2009-06-16 2012-04-25 Schering Corporation Gamma secretase modulators
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
WO2011044185A2 (en) 2009-10-08 2011-04-14 Schering Corporation Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
WO2011044187A1 (en) 2009-10-08 2011-04-14 Schering Corporation Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
WO2011044184A1 (en) 2009-10-08 2011-04-14 Schering Corporation Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
UA108363C2 (uk) 2009-10-08 2015-04-27 Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
WO2012138734A1 (en) 2011-04-07 2012-10-11 Merck Sharp & Dohme Corp. C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
RU2014111055A (ru) 2011-08-22 2015-09-27 Мерк Шарп И Доум Корп. 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение
US20130060021A1 (en) * 2011-09-07 2013-03-07 Satori Pharmaceuticals, Inc. Compounds useful for treating neurodegenerative disorders
ES2745539T3 (es) 2012-03-19 2020-03-02 Buck Inst Res Aging Inhibidores de BACE específicos de APP (ASBI) y uso de los mismos
EP2908825B1 (en) 2012-10-17 2018-04-18 Merck Sharp & Dohme Corp. Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
WO2014062553A1 (en) 2012-10-17 2014-04-24 Merck Sharp & Dohme Corp. Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EP3653609B1 (en) 2013-02-12 2024-04-03 Buck Institute for Research on Aging Hydantoins that modulate bace-mediated app processing
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI902006A7 (fi) * 1987-10-21 1990-04-20 Upjohn Co Menetelmä renniini-inhibiittoreiden valmistamiseksi, jotka sisältävät 1-amino-2-hydroksi-2-heterosyklisen etyylitähteen
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
CN1348442A (zh) 1999-02-26 2002-05-08 默克公司 新的磺胺化合物及其应用
DE19934145C2 (de) * 1999-07-26 2001-05-23 Deutsche Telekom Mobil Verfahren zur Herstellung von Kommunikationsverbindungen zu einer, einem Fahrzeug oder sonstigen mobilen oder ortsfesten Einrichtung zugeordneten, vorzugsweise mobilen Kommunikationsendeinrichtung
US6589978B2 (en) * 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
US6846813B2 (en) 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2410680A1 (en) 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
JP2004534017A (ja) 2001-04-27 2004-11-11 バーテックス ファーマシューティカルズ インコーポレイテッド Baceのインヒビター
US7122675B2 (en) 2001-08-03 2006-10-17 Schering Corporation Gamma secretase inhibitors
MXPA04001014A (es) 2001-08-03 2004-05-27 Schering Corp Novedosos inhibidores de la gama secretasa.
JP3711131B2 (ja) 2001-08-21 2005-10-26 メルク シャープ エンド ドーム リミテッド 新規のシクロヘキシルスルホン
US6673821B2 (en) * 2001-10-22 2004-01-06 Enanta Pharmaceuticals, Inc. Nitrogen heterocycle inhibitors of aspartyl protease
TW200302717A (en) 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
US6974829B2 (en) 2002-05-07 2005-12-13 Elan Pharmaceuticals, Inc. Succinoyl aminopyrazoles and related compounds
AU2002311553A1 (en) 2002-06-26 2004-01-19 Nokia Corporation Method and network element for optimisation of radio resource utilisation in a radio access network
DE60329316D1 (de) * 2002-11-12 2009-10-29 Merck & Co Inc Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
US7618978B2 (en) * 2004-04-22 2009-11-17 Eli Lilly And Company Amides as BACE inhibitors
WO2007058862A2 (en) * 2005-11-16 2007-05-24 Merck & Co., Inc. Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease

Similar Documents

Publication Publication Date Title
JP2008508289A5 (cg-RX-API-DMAC7.html)
RU2007126483A (ru) Гетероциклические ингибиторы аспартилпротеазы
JP4188826B2 (ja) カルシウム塩型スタチンの製造方法
US6605636B2 (en) Atorvastatin hemi-calcium form VII
US6528661B2 (en) Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
RU2009135277A (ru) Гетероциклические ингибиторы аспартильной протеазы
US8470805B2 (en) Processes for preparing piperazinium salts of KMUP and use thereof
AR050184A1 (es) Inhibidores macrociclicos de beta-secretasa
JP2012512165A5 (cg-RX-API-DMAC7.html)
JP2006500370A5 (cg-RX-API-DMAC7.html)
TW200621249A (en) Substituted amide beta secretase inhibitors
RU2359969C2 (ru) Гетероциклические конденсированные соединения, полезные в качестве антидиуретических агентов
JPH04247080A (ja) 3−アリール−4(3h)キナゾリノンcckアンタゴニストおよびそれを含有する医薬製剤
RU2004139029A (ru) Применение замещенных цианопирролидинов и содержащих их комбинированных препаратов для лечения гиперлипидемии и ассоциированных заболеваний
CN1131870C (zh) 新的吡咯磺酰胺化合物
US8080672B2 (en) Crystal form of atorvastatin hemi-calcium and processes for preparation thereof
JP2007534731A5 (cg-RX-API-DMAC7.html)
FR2792199A1 (fr) Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
AU2002241506B2 (en) Atorvastatin hemi-calcium form VII
WO1997029121A1 (fr) Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
WO2010069593A1 (en) Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
ES2330993A1 (es) Combinacion de antagonista del receptor de cannabinoides de tipo pirazolina y estatina.
TWI459946B (zh) Kmup四級銨哌嗪鹽類之製備及醫療用途
AU2002241506A1 (en) Atorvastatin hemi-calcium form VII